These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 24446112)
1. Identification and quantification of the doping agent GHRP-2 in seized unlabelled vials by NMR and MS: a case-report. Gaudiano MC; Valvo L; Borioni A Drug Test Anal; 2014 Mar; 6(3):295-300. PubMed ID: 24446112 [No Abstract] [Full Text] [Related]
2. Glycine-modified growth hormone secretagogues identified in seized doping material. Gajda PM; Holm NB; Hoej LJ; Rasmussen BS; Dalsgaard PW; Reitzel LA; Linnet K Drug Test Anal; 2019 Feb; 11(2):350-354. PubMed ID: 30136411 [TBL] [Abstract][Full Text] [Related]
3. Identification of the growth hormone-releasing hormone analogue [Pro1, Val14]-hGHRH with an incomplete C-term amidation in a confiscated product. Esposito S; Deventer K; Van Eenoo P Drug Test Anal; 2014; 6(11-12):1155-9. PubMed ID: 25283153 [TBL] [Abstract][Full Text] [Related]
4. Synthetic growth hormone releasers detected in seized drugs: new trends in the use of drugs for performance enhancement. Stensballe A; McVeigh J; Breindahl T; Kimergård A Addiction; 2015 Feb; 110(2):368-9. PubMed ID: 25602046 [No Abstract] [Full Text] [Related]
5. Identification of the growth-hormone-releasing peptide-2 (GHRP-2) in a nutritional supplement. Thomas A; Kohler M; Mester J; Geyer H; Schänzer W; Petrou M; Thevis M Drug Test Anal; 2010 Mar; 2(3):144-8. PubMed ID: 20878896 [TBL] [Abstract][Full Text] [Related]
6. Metabolism of growth hormone releasing peptides. Thomas A; Delahaut P; Krug O; Schänzer W; Thevis M Anal Chem; 2012 Dec; 84(23):10252-9. PubMed ID: 23101768 [TBL] [Abstract][Full Text] [Related]
7. A high-throughput LC-MS/MS screen for GHRP in equine and human urine, featuring peptide derivatization for improved chromatography. Timms M; Hall N; Levina V; Vine J; Steel R Drug Test Anal; 2014 Oct; 6(10):985-95. PubMed ID: 24574167 [TBL] [Abstract][Full Text] [Related]
8. Confiscated black market products and nutritional supplements with non-approved ingredients analyzed in the Cologne Doping Control Laboratory 2009. Kohler M; Thomas A; Geyer H; Petrou M; Schänzer W; Thevis M Drug Test Anal; 2010; 2(11-12):533-7. PubMed ID: 21204286 [TBL] [Abstract][Full Text] [Related]
9. Doping control analysis of selected peptide hormones using LC-MS(/MS). Thevis M; Thomas A; Schänzer W Forensic Sci Int; 2011 Dec; 213(1-3):35-41. PubMed ID: 21752560 [TBL] [Abstract][Full Text] [Related]
10. In-house standards derived from doping peptides: Enzymatic and serum stability and degradation profile of GHRP and GHRH-related peptides. González-López NM; Guerra-Acero-Turizo LM; Blanco-Medina I; Barragán-Cárdenas AC; Ramírez-Celis DA; Martínez-Ramírez JA; Fierro-Medina R; García-Castañeda JE; Rivera-Monroy ZJ Biomed Chromatogr; 2023 Dec; 37(12):e5741. PubMed ID: 37688464 [TBL] [Abstract][Full Text] [Related]
11. Determination of growth hormone releasing peptides (GHRP) and their major metabolites in human urine for doping controls by means of liquid chromatography mass spectrometry. Thomas A; Höppner S; Geyer H; Schänzer W; Petrou M; Kwiatkowska D; Pokrywka A; Thevis M Anal Bioanal Chem; 2011 Aug; 401(2):507-16. PubMed ID: 21298258 [TBL] [Abstract][Full Text] [Related]
12. Abuse of recombinant human growth hormone: studies in two different dog models. Rigamonti AE; Scanniffio D; Bonomo SM; Cella SG; Sartorio A; Müller EE Neuroendocrinology; 2004; 79(5):237-46. PubMed ID: 15218318 [TBL] [Abstract][Full Text] [Related]
13. Black market products confiscated in Norway 2011-2014 compared to analytical findings in urine samples. Hullstein IR; Malerod-Fjeld H; Dehnes Y; Hemmersbach P Drug Test Anal; 2015; 7(11-12):1025-9. PubMed ID: 26607218 [TBL] [Abstract][Full Text] [Related]
14. Benzoyltropeine, an unusual substance in street heroin samples. Mari F; Bertol E; Tosti M Bull Narc; 1984; 36(1):59-67. PubMed ID: 6564904 [TBL] [Abstract][Full Text] [Related]
15. Rapid characterization of cocaine in illicit drug samples by 1D and 2D NMR spectroscopy. Yemloul M; Adyatmika IM; Caldarelli S; Ollivier D; Campredon M Anal Bioanal Chem; 2018 Aug; 410(21):5237-5244. PubMed ID: 29947904 [TBL] [Abstract][Full Text] [Related]
16. Identification and structural elucidation of four cannabimimetic compounds (RCS-4, AM-2201, JWH-203 and JWH-210) in seized products. Denooz R; Vanheugen JC; Frederich M; de Tullio P; Charlier C J Anal Toxicol; 2013 Mar; 37(2):56-63. PubMed ID: 23339188 [TBL] [Abstract][Full Text] [Related]
17. Determination of illicit drugs and metabolites in oral fluid by microextraction on packed sorbent coupled with LC-MS/MS. Montesano C; Simeoni MC; Curini R; Sergi M; Lo Sterzo C; Compagnone D Anal Bioanal Chem; 2015 May; 407(13):3647-58. PubMed ID: 25772560 [TBL] [Abstract][Full Text] [Related]
18. The role of ultra high performance liquid chromatography with time of flight detection for the identification of synthetic cannabinoids in seized drugs. Marginean I; Rowe WF; Lurie IS Forensic Sci Int; 2015 Apr; 249():83-91. PubMed ID: 25679986 [TBL] [Abstract][Full Text] [Related]
19. Determination of growth hormone secretagogue pralmorelin (GHRP-2) and its metabolite in human urine by liquid chromatography/electrospray ionization tandem mass spectrometry. Okano M; Sato M; Ikekita A; Kageyama S Rapid Commun Mass Spectrom; 2010 Jul; 24(14):2046-56. PubMed ID: 20552695 [TBL] [Abstract][Full Text] [Related]
20. Carbon isotope ratio determination and investigation of seized testosterone preparations. Forsdahl G; Östreicher C; Koller M; Gmeiner G Drug Test Anal; 2011; 3(11-12):814-9. PubMed ID: 22102298 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]